Our latest report, titled 'Meeting the Challenge of Dementia', summarises our achievements to date and looks ahead to our future role at the leading edge of dementia research.
Introducing the report, Professor John Gallacher, Director of Dementias Platform UK, writes: 'Dementia research is changing, and DPUK is at the forefront of these changes. The global growth in cases of dementia has accelerated the search for new treatments, but new approaches are needed if the search is to be successful. DPUK brings together academic, industry and third sector partners to bridge the gap between mechanism discovery in the laboratory and successful drug trials by developing innovative solutions to help human experimental studies become faster and better.
'The goal of DPUK is to better understand the complexities of dementia in humans, so that drug trials will succeed and we can reduce the failure rates. This enterprise is globally important, and DPUK welcomes collaboration from scientists, wherever they may be, so that dementia will no longer be the blight on humanity that it is today.'